Company: SWKH
Filing Date: 2025-04-30
Form Type: DEFR14A
Source: 0001628280-25-021125
Chunk: 17

Company: SWK Holdings Corp
Filing Date: 2025-04-30
Form: DEFR14A
Chunk 17
---
nington held no outstanding stock awards. For the amount reported in Fees Earned or Paid in Cash, Mr. Pennington elected to receive fully vested shares of common stock of the Company in lieu of cash fees earned in 2024 for 100% of his annual cash consideration for service as a non-employee director and as a member of his respective committees. Mr. Pennington resigned from the board of directors October 1, 2024

(3) As of December 31, 2024 Ms. Dotter held 4,834 outstanding stock awards.

(4) As of December 31, 2024 , Mr. Albright held 4,834 outstanding stock awards.

(5) As of December 31, 2024, Mr. Hatcher held 4,834 outstanding stock awards.

### EXECUTIVE OFFICERS
The following table identifies our executive officers and key employees, and sets forth their current positions at the Company and their ages as of April 22, 2025.

| Name          |     | Positions and Offices Held with the Company |     | Position Held Since |     | Age |
| Joe D. Staggs |     | Chief Executive Officer                     |     |                2023 |     |  44 |
| Adam Rice     |     | Chief Financial Officer                     |     |                2024 |     |  44 |

Joe D. Staggs, age, 44 has been serving as our Chief Executive Officer since January 1, 2023. Mr. Staggs joined the Company as a Senior Analyst in August 2015. He was promoted to Managing Director in January 2020 before being named President and Interim CEO in September 2022. Prior to joining the Company, Mr. Staggs was Vice President of Investments at Annandale Capital. Prior to joining Annandale, he was the first employee at Alistair Capital, a Dallas-based hedge fund. Mr. Staggs previously co-founded PBS Capital, an investment management business investing in pharmaceutical royalties and healthcare equities. Prior to joining PBS, he was a Senior Portfolio Analyst at Highland Capital where he worked on the firm’s healthcare multi-strategy and public equity groups. While at Highland, Mr. Staggs was ranked first out of a class of eight analysts. Mr. Staggs began his career at Raymond James where he was a Senior Equity Research Associate covering healthcare companies and was ranked in the top quartile of all research